Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

• Y Sakata

• A Ohtsu

• N Horikoshi

• K Sugimachi

• Y Mitachi

• T Taguchi

収録刊行物

• European Journal of Cancer

  European Journal of Cancer 34 (11), 1715-1720, 1998-10

  Elsevier BV

キーワード

• Cancer Research
• Oncology

詳細情報

• CRID: 1361699995912852736
• NII論文ID: 30003890224
• DOI: 10.1016/s0959-8049(98)00211-1
• ISSN: 09598049
• ISSN: http://id.crossref.org/issn/00142964
• Web Site: https://api.elsevier.com/content/article/PII:S0959804998002111?httpAccept=text/xml
• Web Site: https://api.elsevier.com/content/article/PII:S0959804998002111?httpAccept=text/plain
• データソース種別:
  • Crossref
  • CiNii Articles